Retatrutide 20mg

Retatrutide is a lyophilized research compound supplied in a 20 mg format. It is a triple-receptor agonist frequently investigated in studies involving glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptor signaling. This format supports laboratories conducting receptor-pharmacology, metabolic-signaling, cellular-response, and multi-pathway peptide research.

For laboratory research use only. Not for human or veterinary use.